Evaluating Combined Sorafenib and Gemcitabine Treatment in HepG2 Cells and a NOD/SCID Mouse Xenograft Model: A Pilot Study.
Liver cancer remains a leading cause of cancer-related mortality due to drug resistance and limited treatment options. There is an urgent need to explore therapeutic strategies to improve outcomes. This pilot study presents a protocol for assessing the potential effects and underlying mechanisms of the combination of s...